MedTrace Logo

COVID-19 Prevalence and Cognitive Deficits in Neurological Patients

NCT04377425 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-09-03

No results posted yet for this study

Summary

The purpose is to investigate the COVID-19 prevalence, associated morbidity and long-term cognitive deficits in consecutive patients presenting with acute neurological symptoms

Conditions

  • Neurological Diseases or Conditions
  • Stroke, Acute
  • Seizure Disorder

Interventions

DIAGNOSTIC_TEST

COVID-19 swap test PCR

COVID-19 swap test PCR performed according to hospital standard operating procedures

Sponsors & Collaborators

  • Aarhus University Hospital

    lead OTHER

Principal Investigators

  • Grethe Andersen, MD · Aarhus University Hospital

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-05-07
Primary Completion
2020-11-29
Completion
2022-06-30

Countries

  • Denmark

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04377425 on ClinicalTrials.gov